Computed Tomography (CT) Scans: Advancements in Oncology Diagnosis and Treatment
DOI:
https://doi.org/10.71147/t415ys60الكلمات المفتاحية:
CT. Oncology. Diagnosis. Treatment. Advancementsالملخص
A comprehensive examination of the advancements in the use of computed tomography (CT) scans for cancer diagnosis and treatment. The article discusses the global rise in cancer incidence and the pressing need for improved diagnostic technologies that can accurately detect, characterize, and monitor tumors. It highlights the various imaging modalities used in cancer diagnosis, including CT, PET, and MRI, and emphasizes the distinctive advantages and limitations of each technique. Materials and Methods: The review underscores the importance of enhancing the signal-to-background ratio, and detection thresholds, and reducing imaging artefacts to improve the effectiveness of these diagnostic tools. Additionally, the article explores the expansion of the cancer diagnostics field through the incorporation of molecular diagnostic techniques, such as flow cytometry, immunohistochemistry, and next-generation sequencing, and their potential to enhance tumor classification, characterization, and personalized treatment approaches. Conclusion: The article provided a piece of detailed information about the current state of CT scan technology in oncology, and highlighted the ongoing advancements and the challenges that remain in improving the clinical and cost-effectiveness of these diagnostic modalities. It emphasized the critical role of continuous research and development in this field to address these challenges and further enhance the early detection and management of cancer.
المراجع
Adebo DA. (2021)Techniques of cardiac CT scan: patient preparation, contrast medium, scanning, and post-processing. In Pediatric Cardiac CT in Congenital Heart Disease. Springer International Publishing ,1 ,15-22
Agarwal, A., Fernando, R., Parameswaran, R., Mishra, A., & Pradhan, R. (2023). CT Imaging in Thyroid Cancer. In Case Studies in Thyroid and Parathyroid Tumors. Springer, Singapore.
Ahmad‐Nejad P, Ashavaid T, Vacaflores Salinas A, et al (2021). Current and future challenges in quality assurance in molecular diagnostics. Clin Chim Acta. ,5(19),239‐246.
AIM at Melanoma Foundation. Tests After Diagnosis. 2024 Retrieved from https://www.aimatmelanoma.org/melanoma-101/how-melanoma-is-diagnosed/additional-evaluation/
Al-Hayek Y, Zheng X, Hayre C, Spuur K.(2022). The influence of patient positioning on radiation dose in CT imaging: A narrative review. Journal of Medical Imaging and Radiation Sciences, 53(4),737-47.
Bae KT. (2010).Intravenous contrast medium administration and scan timing at CT: considerations and approaches. Radiology, 256(1),32-61.
Bansal A, Dhamija E, Chandrashekhara SH, Sahoo RK.(2023). Role of CT in the detection and management of cancer related complications: a study of 599 patients. Ecancermedicalscience, 17,1529.
Baron RL.(1994). Understanding and optimizing use of contrast material for CT of the liver. AJR. American journal of roentgenology,163(2),323-31.
Bar-Shalom R, Guralnik L, Tsalic M, Leiderman M, Frenkel A, Gaitini D. et al.(2005). The additional value of PET/CT over PET in FDG imaging of oesophageal cancer. Eur J Nucl Med Mol Imaging,32(8),918–924.
Bi WL, Hosny A, Schabath MB, et al. (2019).Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin, 69(2), (2020)127‐157.
Brown M, Davis P. (2020). Contrast-enhanced CT scans: a review of techniques and outcomes. Imaging Med, 25(4),301-311.
Brown R, Green T. (2018). Pre-scan protocols and patient preparation. Clin Radiol., 73(7),1234-1240.
Buzaid AC, Sandler AB, Mani SR, Curtis AM, Poo WJ, Bolognia JL, Ariyan S. (1993). Role of computed tomography in the staging of primary melanoma. Journal of Clinical Oncology, (4),638-43.
Cohade C, Osman M, Leal J, Wahl RL.(2003). Direct comparison of (18)F-FDG Pet and PET/CT in patients with colorectal carcinoma. J Nucl Med, 44,1797–1803.
Creytens D. (2021).Molecular classification of soft tissue and bone tumors. Diagnostics, 11(12),2326.
Czernin J, Allen-Auerbach M, Schelbert HR.(2007). Improvements in cancer staging withPET/CT: Literature-based evidence as of September 2006. J Nucl Med.,48,78S–88S.
Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, Townsend DW, Berland LL, Parker JA, Zubal G, Cronin V.(2006). Procedure guideline for SPECT/CT imaging 1.0. Journal of Nuclear Medicine,47(7),1227-34
DermNet.(2020). Radiographic investigations in melanoma. Retrieved from https://dermnetnz.org/topics/radiographic-investigations-in-melanoma
Dillon WP. (2024).50th anniversary of computed tomography: past and future applications in clinical neuroscience. Neurosurgery,94(1),1-10.
Diwakar M, Kumar M.(2018). A review on CT image noise and its denoising. Biomedical Signal Processing and Control, 1;42,73-88.
Evans K, Reed B. (2019). CT scanner technology: developments and innovations. Radiol Technol, 90(2),123-130.
Falaschi F, Romei C, Fiorini S, Lucchi M. (2018). Imaging of malignant pleural mesothelioma: it is possible a screening or early diagnosis program?-a systematic review about the use of screening programs in a population of asbestos exposed workers. J Thorac Dis, 10(Suppl 2):S262-S268.
Fass L. (2008). Imaging and cancer: a review. Mol Oncol, 2(2),115‐152.
Frangioni JV. (2008). New technologies for human cancer imaging. J Clin Oncol, 26(24),4012‐4021.
Garnett R.(2020). A comprehensive review of dual-energy and multi-spectral computed tomography. Clinical imaging, 1;(67),160-9.
Goerres GW, Stupp R, Barghouth G, Hany TF, Pestalozzi B, Dizendorf E. et al.(2005). The value of PET, CT and in-line PET-CT in patients with gastrointestinal stromal tumors: Long term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging, 32,153–162.
Grisaru D, Almog B, Levine C, Metser U, Fishman A, Lerman H. et al. (2004).The diagnostic accuracy of 18F-fluodeoxyglucose PET/CT in patients with gynecological malignancies. Gynec Oncol, 94, 680–684.
Gupta, Surbhi et al.(2022). “Deep learning techniques for cancer classification using microarray gene expression data.” Frontiers in physiology vol. 13 952709.
Harris MA, Snaith B, Clarke R. (2016). Strategies for assessing renal function prior to outpatient contrast-enhanced CT: a UK survey. The British Journal of Radiology, 1,89(1067):20160077.
Harris S, Morgan T. (2018). The physics of CT imaging: principles and applications. Radiology Phys, 13(3),202-210.
Heinrich S, Goerres GW, Schafer M, Sagmeister M, Bauerfeind P, Pestalozzi BC. et al. (2005). Positron emission tomography/Computed tomography influences on the management of respectable pancreatic cancer and its cost-effectiveness. Ann Surg, 242,235–243.
Hsieh J, Flohr T. (2021). Computed tomography recent history and future perspectives. J Med Imaging (Bellingham), 8(5),052109.
Jiang H, Flohr T, et al. (2024).Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027. Lung Cancer, 108,1-10.
Johnson L, Lee M. (2019).Contrast materials in computed tomography: a review. Radiology Today, 30(2), 45-52.
Lewis D, Hall E. (2021).Patient positioning and its impact on imaging quality. J Comput Assist Tomogr, 45(5),456-462.
Lopci E, Nanni C, Castellucci P, et al.(2010). Imaging with non‐FDG PET tracers: outlook for current clinical applications. Insights Imaging, 1(5–6), 373‐385.
Jung H. (2010). Basic physical principles and clinical applications of computed tomography. Progress in Medical Physics, 32(1),1-7.
Lusic H, Grinstaff MW.(2013). X-ray-computed tomography contrast agents. Chemical reviews, 113(3),1641-66.
Madireddy S, Verma A, Dwarakanath BS, Papineni RVL. (2022). Technological advancements in brachytherapy of cancer. Phys Open, 11,100109.
Mahfouz ME, Rodrigo JP, Takes RP, et al. (2020).Current potential and limitations of molecular diagnostic methods in head and neck cancer. Eur Arch Otorhinolaryngol, 267(6),851‐860.
Mattocks CJ, Morris MA, Matthijs G, et al.(2010). A standardized framework for the validation and verification of clinical molecular genetic tests. Eur J Hum Genet, 18(12), 1276‐1288.
Medina‐Lara A, Grigore B, Lewis R, et al. (2020).Cancer diagnostic tools to aid decision‐making in primary care: mixed‐methods systematic reviews and cost‐effectiveness analysis. Health Technol Assess, 24(66),1‐332.
Meghzifene A, Dance DR, McLean D, Kramer HM.(2010). Dosimetry in diagnostic radiology. Eur J Radiol, 76(1),11‐14.
Mettler FA, Wiest PW, Locken JA, Kelsey CA. (2000). CT scanning: patterns of use and dose. Journal of Radiological Protection, 20(4),353
Montagnana M, Lippi G. (2017). Cancer diagnostics: current concepts and future perspectives. Ann Transl Med, 5(13),268.
Normanno N, Rachiglio AM, Roma C, et al. (2013). Molecular diagnostics and personalized medicine in oncology: challenges and opportunities. J Cell Biochem, 114(3),514‐524.
Ponzo FA. (2008). Patient Preparation and Scanning Considerations for PET and PET/CT. Positron emission tomography-computed tomography: a disease-oriented approach, 7,33-8.
Pulumati A, Pulumati A, Dwarakanath BS, Verma A, Papineni RVL.(2023). Technological advancements in cancer diagnostics: Improvements and limitations. Cancer Rep (Hoboken), 6(2),e1764.
Raza F, Zafar H, You X, Khan A, Wu J, Ge L. (2019). Cancer nanomedicine: focus on recent developments and self‐assembled peptide nanocarriers. J Mater Chem B, 7(48),7639‐7655.
Scharf J, Chouchane M, Finegan DP, Lu B, Redquest C, Kim MC, Yao W, Franco AA, Gostovic D, Liu Z, Riccio M, Zelenka F, Doux JM, Meng YS.(2022). Bridging nano- and microscale X-ray tomography for battery research by leveraging artificial intelligence. Nat Nanotechnol, 17(5),446-459.
Schulz RA, Stein JA, Pelc NJ.(2021). How CT happened: the early development of medical computed tomography. Journal of Medical Imaging, 8(5),052-110.
Sung H, Ferlay J, Siegel RL, et al.(2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 71(3),209‐249.
Smith J, Doe A. (2020). Preparation for diagnostic imaging: guidelines and considerations. J Med Imaging, 15(3),123-134.
Sung JC, Sodickson A, Ledbetter S.(2009). Outside CT imaging among emergency department transfer patients. Journal of the American College of Radiology, 6(9), 626-32.
Tettero JM, Freeman S, Buecklein V, et al.(2022). Technical aspects of flow cytometry‐based measurable residual disease quantification in acute myeloid leukemia: experience of the European LeukemiaNet MRD working party. HemaSphere, 6(1),e 676.
Tempany CMC, Jayender J, Kapur T, et al. (2015). Multimodal imaging for improved diagnosis and treatment of cancers. Cancer, 121(6),817‐827
Thompson G, Parker L. Patient guidelines for CT imaging. (2022). Med Imaging Tech, 19(1), 89-96.
Vannier MW. (2009). CT clinical perspective: Challenges and the impact of future technology developments. In2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society, (pp. 1909-1912). IEEE.
Wu MZ, McInnes MD, Blair Macdonald D, Kielar AZ, Duigenan S. (2014).CT in adults: systematic review and meta-analysis of interpretation discrepancy rates. Radiology, 270(3),717-35.
Walter W, Pfarr N, Meggendorfer M, Jost P, Haferlach T, Weichert W. (2022).Next‐generation diagnostics for precision oncology: preanalytical considerations, technical challenges, and available technologies. Semin Cancer Biol, 9(84), 3‐15.
Tatsumi M, Cohade C, Mourtzikos K, Fishman EK, Wahl RL. (2005). Initial experience with FDG PET-CT in the evaluation of breast cancer. Eur J Nucl Med Mol Imaging, 33, 254–262.
Trattner S, Pearson GD, Chin C, Cody DD, Gupta R, Hess CP, Kalra MK, Kofler Jr JM, Krishnam MS, Einstein AJ. (2014). Standardization and optimization of CT protocols to achieve low dose. Journal of the American College of Radiology, 11(3),271-8.
Von Schulthess GK, Steinert HC, Hany TF. (2006). Integrated PET/CT: current applications and future directions. Radiol, 238, 405–422.
Walker J, Adams L.(2019). Understanding CT scanner operations and noise. Radiol Technol, 91(1),44-50.
White H, Black J. (2021). Advances in contrast agents for CT scans. Imaging Sci, 12(4), 345-356.
Wilson M, Clarke P.(2017). Administrative aspects of CT imaging: a comprehensive guide. Health Manage Rev, 22(6),567-574.
Zangheri B, Messa C, Picchio M, Gianolli L, Landoni C, Fazio F. (2004). PET/CT and breast cancer. Eur J Nucl Med Mol Imaging, 31,S135–S142.
التنزيلات
منشور
إصدار
القسم
الرخصة
الحقوق الفكرية (c) 2025 nagat bolowia (Author)
هذا العمل مرخص بموجب Creative Commons Attribution-NonCommercial 4.0 International License.
